Details

Autor(en) / Beteiligte

• de Carvalho Lima, Elidamar Nunes
• Diaz, Ricardo Sobhie
• Justo, João Francisco
• Castilho Piqueira, José Roberto

Titel

Advances and Perspectives in the Use of Carbon Nanotubes in Vaccine Development

Ist Teil von

• International journal of nanomedicine, 2021-01, Vol.16, p.5411-5435

Ort / Verlag

New Zealand: Dove Medical Press Limited

Erscheinungsjahr

2021

Link zum Volltext

Quelle

MEDLINE

Beschreibungen/Notizen

• Advances in nanobiotechnology have allowed the utilization of nanotechnology through nanovaccines. Nanovaccines are powerful tools for enhancing the immunogenicity of a specific antigen and exhibit advantages over other adjuvant approaches, with features such as expanded stability, prolonged release, decreased immunotoxicity, and immunogenic selectivity. We introduce recent advances in carbon nanotubes (CNTs) to induce either a carrier effect as a nanoplatform or an immunostimulatory effect. Several studies of CNT-based nanovaccines revealed that due to the ability of CNTs to carry immunogenic molecules, they can act as nonclassical vaccines, a quality not possessed by vaccines with traditional formulations. Therefore, adapting and modifying the physicochemical properties of CNTs for use in vaccines may additionally enhance their efficacy in inducing a T cell-based immune response. Accordingly, the purpose of this study is to renew and awaken interest in and knowledge of the safe use of CNTs as adjuvants and carriers in vaccines.